Interact to see
Advertisement
Advertisement
FDAGX vs RYCPX
FDAGX vs RYCPX Comparison
Open Charts FDAGX vs RYCPX
Fidelity Advisor Consumer Staples A
Price$83.91
Change+$0.49 (+0.59%)
VolumeN/A
Net Assets1.14B
Rydex Consumer Products C
Price$84.46
Change+$0.42 (+0.50%)
VolumeN/A
Net Assets35.77M
FDAGX vs RYCPX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FDAGX vs. RYCPX commentary
Sep 17, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDAGX is a Hold and RYCPX is a Hold.
FUNDAMENTALS
Fundamentals
FDAGX has more cash in the bank: 1.14B vs. RYCPX (35.8M). RYCPX pays higher dividends than FDAGX: RYCPX (2.59) vs FDAGX (1.63). FDAGX was incepted earlier than RYCPX: FDAGX (19 years) vs RYCPX (24 years). RYCPX (2.43) is less costly to investors than FDAGX (0.97). RYCPX is a more actively managed with annual turnover of: 57.00 vs. FDAGX (45.00). FDAGX has a lower initial minimum investment than RYCPX: FDAGX (0) vs RYCPX (2500). RYCPX IRA initial investment is lower compared to FDAGX: RYCPX (1000) vs FDAGX (500). RYCPX (-14.89) and FDAGX (-15.16) have marching annual gain over last year. FDAGX return over 5 years is better than : 3.06 vs. RYCPX (-40.50).
| FDAGX | RYCPX | FDAGX / RYCPX | |
| Total Expense Ratio | 0.97 | 2.38 | 41% |
| Annual Report Gross Expense Ratio | 0.97 | 2.43 | 40% |
| Fund Existence | 19 years | 24 years | - |
| Gain YTD | -4.873 | 0.119 | -4,090% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 2500 | - |
| Min. Initial Investment IRA | 500 | 1000 | 50% |
| Net Assets | 1.14B | 35.8M | 3,187% |
| Annual Yield % from dividends | 1.63 | 2.59 | 63% |
| Returns for 1 year | -15.16 | -14.89 | 102% |
| Returns for 3 years | 0.70 | -26.32 | -3% |
| Returns for 5 years | 3.06 | -40.50 | -8% |
| Returns for 10 years | 2.60 | -39.73 | -7% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement